.Pharmacolibrary.Drugs.ATC.V.V09IA01 .Pharmacolibrary.Drugs.ATC.V.V09IA01| name: | Technetium99mtcAnticarcinoembryonicantigenAntibody | |
| ATC code: | V09IA01 | route: | intravenous |
| compartments: | 2 | |
| dosage: | 0.5 | mg |
| volume of distribution: | 4 | L |
| clearance: | 0.18 | L/h |
| other parameters in model implementation | ||
Technetium (99mTc) antiCarcinoEmbryonicAntigen antibody is a radiolabeled monoclonal antibody used in the diagnosis and imaging of tumors expressing the carcinoembryonic antigen (CEA), such as certain colorectal, medullary thyroid, and other adenocarcinomas. It is administered as a radiopharmaceutical agent for tumor localization using nuclear medicine techniques. Its clinical use is limited and not widespread today, with most imaging procedures replaced by more advanced PET/CT agents.
Pharmacokinetic parameter estimates for technetium (99mTc) antiCEA antibody based on typical monoclonal antibody behavior in adults. No published primary PK values are available; these values are estimated from analogous radiolabeled antibody agents and general principles.